Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Long-awaited results from the ANCHOR study suggest screening to detect precancerous lesions should be part of routine care.
The vaccine regimen tested in the Imbokodo trial was similar to the J&J COVID-19 vaccine, but an mRNA approach may hold more promise.
An experimental vaccine combination did not protect people from acquiring HIV in a large clinical trial.
Right now, it typically takes six years after an HIV drug is approved to obtain data for pregnant people.
I’m grateful I can apply so many of the painful lessons from my past to help diminish the impact of this new pandemic.
We got COVID-19 vaccines in record time. Why are HIV vaccines taking so long?
The new prevention approach shows promise, but it isn’t heading to the clinic anytime soon.
The week of March 6 – March 10, 2021 I had the privilege of attending the Conference on Retroviruses and Opportunistic Infections (CROI).
Certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed.
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Some experts want to hold out for a more optimal vaccine. Others believe accepting the best possible vaccine sooner than later is ideal.
None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.
MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.